Shares in the small-cap biotech jumped 37.5% to 9.9 cents each after reporting positive COVID-19 animal trial results today.
Biotron Limited is engaged in the...
Biogen Inc. has notified the European Medicines Agency (EMA) of its decision to withdraw its Marketing Authorization Application (MAA) for aducanumab for the treatment...
Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D round co-led by Altimeter Capital and...
Halozyme Therapeutics, Inc. and Antares Pharma, Inc. announced that the companies have entered into a definitive agreement pursuant to which Halozyme will acquire Antares...
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong,...
Royal Philips, a global leader in health technology, and Oulu University Hospital in Finland Apr 11th announced a strategic 10-year partnership agreement to support...